We have characterised for the first time the general and neurological side effects experienced when using a series of chronic non-lethal cisplatin + paclitaxel schedules in Wistar rats, selected according to our previous experience and the animals' maximum tolerated dose. At the pathological level, the use of combination schedules was definitely more toxic at the kidney and sternal bone marrow level than the single-agent schedules. At the neurophysiological examination based on the assessment of the nerve conduction velocity measurement in the tail nerve, we identified only one combination schedule that was more neurotoxic than the similar schedules based on single-agent administration. This observation was confirmed by the neuropathological examination performed on the sciatic nerve, dorsal root ganglia, ventral and dorsal roots. Our study supports the hypothesis that the general and, to a lesser extent, neurological effects of a combination of cisplatin and paclitaxel are different from those of the administration of both drugs as single agents. We believe that these models may be useful for testing neuroprotective strategies.

Carozzi, V., Chiorazzi, A., Canta, A., Oggioni, N., Gilardini, A., RODRIGUEZ MENENDEZ, V., et al. (2009). Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity. EUROPEAN JOURNAL OF CANCER, 45(4), 656-665 [10.1016/j.ejca.2008.10.038].

Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity

CAROZZI, VALENTINA ALDA;CHIORAZZI, ALESSIA;CANTA, ANNALISA ROSANNA;OGGIONI, NORBERTO;RODRIGUEZ MENENDEZ, VIRGINIA;AVEZZA, FEDERICA;CERESA, CECILIA;NICOLINI, GABRIELLA;BOSSI, MARIO;CAVALETTI, GUIDO ANGELO
2009

Abstract

We have characterised for the first time the general and neurological side effects experienced when using a series of chronic non-lethal cisplatin + paclitaxel schedules in Wistar rats, selected according to our previous experience and the animals' maximum tolerated dose. At the pathological level, the use of combination schedules was definitely more toxic at the kidney and sternal bone marrow level than the single-agent schedules. At the neurophysiological examination based on the assessment of the nerve conduction velocity measurement in the tail nerve, we identified only one combination schedule that was more neurotoxic than the similar schedules based on single-agent administration. This observation was confirmed by the neuropathological examination performed on the sciatic nerve, dorsal root ganglia, ventral and dorsal roots. Our study supports the hypothesis that the general and, to a lesser extent, neurological effects of a combination of cisplatin and paclitaxel are different from those of the administration of both drugs as single agents. We believe that these models may be useful for testing neuroprotective strategies.
Articolo in rivista - Articolo scientifico
Combination; Toxicity; Female; Paclitaxel; Wistar; Peripheral Nervous System Diseases; Rats; Weight Loss; Animals; Neurotoxicity Syndromes; Disease Models, Animal; Bone Marrow Diseases; Ganglia, Spinal; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Cisplatin
English
2009
45
4
656
665
none
Carozzi, V., Chiorazzi, A., Canta, A., Oggioni, N., Gilardini, A., RODRIGUEZ MENENDEZ, V., et al. (2009). Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity. EUROPEAN JOURNAL OF CANCER, 45(4), 656-665 [10.1016/j.ejca.2008.10.038].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/9707
Citazioni
  • Scopus 34
  • ???jsp.display-item.citation.isi??? 33
Social impact